← Pipeline
PreclinicalPreclinical programmePositive signal
Preclinical cell therapy
Cambridge directly induced NSCs
Directly induced neural stem-cell transplantation
Practical availability: Preclinical — not available as a clinical intervention
- Compound / intervention
- Directly induced neural stem-cell transplantation
- Mechanism
- Directly induced neural stem-cell transplantation
- Development stage
- Preclinical cell therapy
- Status
- Peer-reviewed proof-of-concept in chronic demyelination models
- Evidence level
- Preclinical only • no proven clinical benefit in MS
Next substantive checkpoint
Delivery, dosing and safety work needed before MS clinical translation
Related substantive developments
No separate substantive update is currently linked.